drugset / Trial / NCT01424449

A PET Study in Healthy Volunteers

NCT01424449

Phase 1 Completed 7 enrolled GlaxoSmithKline
NaSingle-groupOpen-label

Summary

This will be an open label, non-randomised \[11C\]PHNO PET study using healthy male volunteers. Each volunteer will undergo 4 \[11C\]PHNO PET scans to allow for further characterisation of this radioligand and examine the effects of \[11C\]PHNO mass carry-over and displaceable binding in the brain. This study aims to obtain data from 6 evaluable subjects.

Timeline

Start
2010-01
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Background Aripiprazole Other / unclassified 15 mg

Indications